Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
NCT05428358

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

Led by University of Aarhus · Updated on 2026-04-29

200

Participants Needed

3

Research Sites

326 weeks

Total Duration

On this page

Sponsors

U

University of Aarhus

Lead Sponsor

R

Rigshospitalet, Denmark

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.

CONDITIONS

Official Title

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pancreatic cancer patients considered to have a locally resectable or borderline resectable tumor by the local hepato-pancreato-biliary multidisciplinary team board
  • No liver metastases on CT
  • At least 18 years old and able to provide informed consent
  • Expected pancreatic ductal adenocarcinoma based on CT scan
Not Eligible

You will not qualify if you...

  • Metastatic disease
  • Prior receipt of neoadjuvant chemotherapy or downstaging/-sizing treatment
  • Comorbidity rendering major surgery unfeasible (inoperable)
  • No informed consent
  • Unable to undergo MRI (Kidney insufficiency (eGFR < 60 ml/min/1.73 m2 body surface area); Claustrophobia; Cardiac pacemaker)
  • Postoperative histology other than adenocarcinoma of pancreato-biliary origin
  • MRI with liver-specific contrast performed during standard workup

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Aalborg University Hospital

Aalborg, Denmark

Actively Recruiting

2

Aarhus University Hospital

Aarhus, Denmark, 8200

Actively Recruiting

3

Rigshospitalet

Copenhagen, Denmark

Actively Recruiting

Loading map...

Research Team

J

Jakob Kirkegård, MD, PhD

CONTACT

F

Frank Mortensen, MD, DMSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here